Johnson & Johnson Income Statement

JNJ / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.

Johnson & Johnson reported $94.2B in revenue and $26.8B in net income for FY2025. Revenue has grown at a 2.7% compound annual rate over the past 14 years.

Based on SEC 10-K filings.

Key Data Points

Strong profit margin: 27.3%
Strong return on equity: 31.7%

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenue	$94.2B	$88.8B	$85.2B	$80.0B	$78.7B	$82.6B	$82.1B	$81.6B	$76.5B	$71.9B	$70.1B	$74.3B	$71.3B	$67.2B	$65.0B
Cost of Revenue	$30.3B	$27.5B	$26.6B	$24.6B	$23.4B	$28.4B	$27.6B	$27.1B	$25.4B	$21.8B	$21.5B	$22.7B	$22.3B	$21.7B	$20.4B
Gross Profit	$63.9B	$61.4B	$58.6B	$55.4B	$55.3B	$54.2B	$54.5B	$54.5B	$51.0B	$50.1B	$48.5B	$51.6B	$49.0B	$45.6B	$44.7B
SG&A Expense	$23.7B	$22.9B	$21.5B	$20.2B	$20.1B	$22.1B	$22.2B	$22.5B	$21.5B	$20.1B	$21.2B	$22.0B	$21.8B	$20.9B	$21.0B
R&D Expense	$109.0M	$1.8B	$483.0M	$0	$0	$12.2B	$11.4B	$10.8B	$10.6B	$9.1B	$9.0B	$8.5B	$8.2B	$7.7B	$7.5B
Operating Income	-	-	-	-	-	-	-	-	-	-	-	$21.6B	$16.4B	$15.0B	$13.8B
Interest Expense	-	-	$772.0M	$276.0M	$183.0M	$201.0M	$318.0M	$1.0B	$934.0M	$726.0M	$552.0M	$533.0M	$482.0M	$532.0M	$571.0M
Income Tax	$5.8B	$2.6B	$1.7B	$3.0B	$1.4B	$1.8B	$2.2B	$2.7B	$16.4B	$3.3B	$3.8B	$4.2B	$1.6B	$3.3B	$2.7B
Net Income	$26.8B	$14.1B	$35.2B	$17.9B	$20.9B	$14.7B	$15.1B	$15.3B	$1.3B	$16.5B	$15.4B	$16.3B	$13.8B	$10.9B	$9.7B
EPS (Basic)	$13.88	$6.83	$7.93	$5.59	$5.72	$5.70	$0.48	$6.04	$5.56	$5.80	$4.92	$3.94	$3.54	$4.85	$4.45
EPS (Diluted)	$13.72	$6.73	$7.81	$5.51	$5.63	$5.61	$0.47	$5.93	$5.48	$5.70	$4.81	$3.86	$3.49	$4.78	$4.40
Shares Outstanding	2.6B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.8B	2.8B	2.9B	2.9B	2.8B	2.8B	2.8B	2.8B
Gross Margin	67.9%	69.1%	68.8%	69.3%	70.3%	65.6%	66.4%	66.8%	66.7%	69.7%	69.3%	69.4%	68.7%	67.8%	68.7%
Operating Margin	-	-	-	-	-	-	-	-	-	-	-	29.0%	23.0%	22.3%	21.2%
Profit Margin	28.5%	15.8%	41.3%	22.4%	26.5%	17.8%	18.4%	18.8%	1.7%	23.0%	22.0%	22.0%	19.4%	16.1%	14.9%

Other Financial Statements

Balance Sheet Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Johnson & Johnson Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Revenue

$94.2B

$88.8B

$85.2B

$80.0B

$78.7B

$82.6B

$82.1B

$81.6B

$76.5B

$71.9B

$70.1B

$74.3B

$71.3B

$67.2B

$65.0B

Cost of Revenue

$30.3B

$27.5B

$26.6B

$24.6B

$23.4B

$28.4B

$27.6B

$27.1B

$25.4B

$21.8B

$21.5B

$22.7B

$22.3B

$21.7B

$20.4B

Gross Profit

$63.9B

$61.4B

$58.6B

$55.4B

$55.3B

$54.2B

$54.5B

$51.0B

$50.1B

$48.5B

$51.6B

$49.0B

$45.6B

$44.7B

SG&A Expense

$23.7B

$22.9B

$21.5B

$20.2B

$20.1B

$22.1B

$22.2B

$22.5B

$21.5B

$20.1B

$21.2B

$22.0B

$21.8B

$20.9B

$21.0B

R&D Expense

$109.0M

$1.8B

$483.0M

$12.2B

$11.4B

$10.8B

$10.6B

$9.1B

$9.0B

$8.5B

$8.2B

$7.7B

$7.5B

Operating Income

$21.6B

$16.4B

$15.0B

$13.8B

Interest Expense

$772.0M

$276.0M

$183.0M

$201.0M

$318.0M

$1.0B

$934.0M

$726.0M

$552.0M

$533.0M

$482.0M

$532.0M

$571.0M

Income Tax

$5.8B

$2.6B

$1.7B

$3.0B

$1.4B

$1.8B

$2.2B

$2.7B

$16.4B

$3.3B

$3.8B

$4.2B

$1.6B

$3.3B

$2.7B

Net Income

$26.8B

$14.1B

$35.2B

$17.9B

$20.9B

$14.7B

$15.1B

$15.3B

$1.3B

$16.5B

$15.4B

$16.3B

$13.8B

$10.9B

$9.7B

EPS (Basic)

$13.88

$6.83

$7.93

$5.59

$5.72

$5.70

$0.48

$6.04

$5.56

$5.80

$4.92

$3.94

$3.54

$4.85

$4.45

EPS (Diluted)

$13.72

$6.73

$7.81

$5.51

$5.63

$5.61

$0.47

$5.93

$5.48

$5.70

$4.81

$3.86

$3.49

$4.78

$4.40

Shares Outstanding

2.6B

2.7B

2.8B

2.9B

2.8B

Gross Margin

67.9%

69.1%

68.8%

69.3%

70.3%

65.6%

66.4%

66.8%

66.7%

69.7%

69.3%

69.4%

68.7%

67.8%

68.7%

Operating Margin

29.0%

23.0%

22.3%

21.2%

Profit Margin

28.5%

15.8%

41.3%

22.4%

26.5%

17.8%

18.4%

18.8%

1.7%

23.0%

22.0%

19.4%

16.1%

14.9%